‘Immune evasion’ uncommon in M. tuberculosis
May 24th, 2010 - 12:38 pm ICT by ANILondon, May 24 (ANI): The strategy of “immune evasion”, which is common to many viruses, bacteria and parasites, is uncommon to M. tuberculosis where the antigens remain strikingly unchanged and homogenous, found scientists at NYU Langone Medical Center.
The study suggests that M. tuberculosis antigens do not mutate because they hope to be recognized by the body’s immune system- perhaps because the host immune mechanism that leads to the typical lung destruction and cough can contribute to the spread of the disease.
The discovery could change the direction of vaccine research and eventually result in a new focus on different targets of immune response to the bacteria.
“The finding that the tuberculosis bacterium acts completely differently from other pathogens is quite surprising and unexpected. If you get infected with the influenza virus, for example, the body’s immune system recognizes it and tends to eliminate it. In tuberculosis, our immune response doesn’t get rid of it - it tends to hold on to it for a while - keeping the bacteria under partial control,” Nature quoted Dr. Joel Ernst, lead author of the study, as saying.
The study found that instead of “suffering” from being recognized, recognition of tuberculosis antigens actually benefit the bacteria - and it is this recognition that helps the bacteria to be transmitted from person to person.
For the study, scientists used a novel high-throughput DNA sequencing method to analyze the whole genomes of 22 clinical strains of M. tuberculosis from different parts of the world.
They then determined that the number of and type of mutations that occurred in antigens is much lower compared to other regions of the M. tuberculosis genome.
The study was published in Nature Genetics. (ANI)
- How bacteria developed resistance to antibiotics - Dec 28, 2010
- Secret of bacteria's immune system unlocked - Nov 05, 2010
- Discovery could lead to 'next-gen' vaccines - Apr 08, 2012
- Newly discovered pathway could pave way for treatments for immune diseases - Dec 24, 2009
- New tool to make fight against tuberculosis easier - Oct 09, 2010
- Species have to continue evolving to survive - Feb 26, 2010
- Scientists find TB disease mechanism along with compound to block it - Feb 16, 2010
- A bug that nips malaria in the bud - May 13, 2011
- New cell type boosts immunity to infection - Nov 30, 2011
- Study uncovers DNA sequence variations that make the heart beat - Nov 15, 2010
- Anthrax shot protects simians from lethal infection - Jan 13, 2012
- TB-drugome may pave way for anti-TB drug discovery - Nov 09, 2010
- 'No mutation of swine flu virus' - Apr 11, 2012
- New approach to fight HIV could spur vaccine development - Sep 28, 2010
- Obsession with cleanliness 'could be making people depressed' - Apr 20, 2011
Tags: antigens, control nature, dna sequencing, dr joel, genomes, high throughput, immune evasion, immune mechanism, immune response, influenza virus, joel ernst, nature genetics, new focus, nyu langone, pathogens, person to person, throughput dna, tuberculosis, tuberculosis bacterium, vaccine research